fda approved compounding pharmacies tirzepatide Compounded for Weight Loss Have patients been harmed by

However, we estimated this effect not to be significant

The treatment was continued 36-weeks with the dose 2.4 mg/day

Available from: This allows 503B facilities to compound medications and distribute them to healthcare providers without having to submit those medications for FDA review and approval

Most chose to drop it or never offered it at all

Ideal candidates include adults who have: Achieved 10% weight loss on GLP-1 medications and are now ready to transition off with professional support Experienced appetite suppression during treatment but are seeking drug-free, lifestyle-driven strategies for continued success Encountered weight regain after previous attempts at maintenance, despite best efforts Struggled with emotional eating, stress-related weight fluctuations , or inconsistent motivation Whether you're stepping down from medication or recommitting to your goals, our weight management program offers a clinically supported, holistic path forward